VapC12 ribonuclease toxin modulates host immune response during Mycobacterium tuberculosis infection

Shaifali Tyagi1,2, Srikanth Sadhu3, Taruna Sharma1,2

  • 1Mycobacterial Pathogenesis Laboratory, Translational Health Science and Technology Institute, Faridabad, Haryana, India.

PubMed

Insights

The VapC12 toxin in tuberculosis (TB) persistence is linked to host immune response. Disrupting VapC12 improves anti-TB treatment by modulating inflammation and bacterial load.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Antibiotic persistence is key to controlling multidrug-resistant (MDR) tuberculosis (TB).
  • The VapC12 ribonuclease, activated by cholesterol, is crucial for TB persistence.
  • Understanding VapC12's role in host-pathogen interaction is vital for new TB therapies.

Purpose of the Study:

  • To investigate the role of VapC12 in the host immune response during TB infection.
  • To determine the impact of VapC12 deletion on disease progression and treatment efficacy.
  • To elucidate the molecular mechanisms underlying VapC12-mediated immune modulation.

Main Methods:

  • Comparative analysis of wild-type and ΔvapC12 infected mouse models.
  • Assessment of pro-inflammatory responses, pathogen load, and treatment outcomes.
  • Investigation of the dependency on Toll-like receptor 4 (TLR4) for observed phenotypes.

Main Results:

  • Mice infected with ΔvapC12 exhibited a heightened pro-inflammatory response and increased pathogen burden compared to wild-type.
  • Deletion of VapC12 led to improved response to anti-TB treatment.
  • The observed phenotype of ΔvapC12 was dependent on the TLR4 receptor.
  • Failure to resolve early inflammation in ΔvapC12 infected mice resulted in hyperinflammation and altered T-cell responses.

Conclusions:

  • VapC12 toxin plays a significant role in modulating the host's innate immune response.
  • VapC12 contributes to long-term Mycobacterium tuberculosis survival by manipulating host immunity.
  • Targeting VapC12 may represent a novel therapeutic strategy for combating TB, particularly MDR-TB.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
779
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K